Literature DB >> 9696404

Inhibition of neuronal dopamine uptake by some antiallergic drugs.

K Matsunaga1, T Sato, H Shuto, Y Tsuruta, K Suemaru, Y Gomita, R Oishi.   

Abstract

The effects of 10 antiallergic drugs (astemizole, azelastine, ebastine, emedastine, epinastine, ketotifen, oxatomide, terfenadine, pemirolast and tranilast) on neuronal dopamine uptake were examined. Some drugs examined showed a concentration-dependent inhibition of [3H]dopamine uptake into synaptosomal preparations of the rat striatum. The inhibition constant (Ki) values were 231-876 nM for ebastine, terfenadine, oxatomide and astemizole. The specific binding of [3H] (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine) (GBR12935) to the rat striatal membranes was also inhibited by these antiallergic drugs. There was a good correlation between the degrees of inhibition of [3H]dopamine uptake and [3H]GBR12935 binding. Then, the behavioral excitement induced by L-DOPA (100 mg/kg, s.c.) plus pargyline hydrochloride (80 mg/kg, i.p.) in mice was significantly enhanced by i.p. treatment with ebastine (10 mg/kg) and astemizole (5 mg/kg). These results suggest that the neuronal dopamine uptake is inhibited by some antiallergic drugs, especially ebastine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696404     DOI: 10.1016/s0014-2999(98)00253-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward.

Authors:  Christian Brabant; Etienne Quertemont; Christelle Anaclet; Jian-Sheng Lin; Hiroshi Ohtsu; Ezio Tirelli
Journal:  Psychopharmacology (Berl)       Date:  2006-10-28       Impact factor: 4.530

2.  Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.

Authors:  Erik B Oleson; Mark J Ferris; Rodrigo A España; Jill Harp; Sara R Jones
Journal:  Eur J Pharmacol       Date:  2012-03-15       Impact factor: 4.432

Review 3.  Ebastine: an update of its use in allergic disorders.

Authors:  M Hurst; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis.

Authors:  Eef L Theunissen; Marinus J P G van Kroonenburgh; Jeroen A van Deursen; Ciska Blom-Coenjaerts; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2006-05-23       Impact factor: 4.530

5.  Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice.

Authors:  Junzo Kamei; Kayo Morita; Shigeo Miyata; Kenji Onodera
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

6.  Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats.

Authors:  Jae H Jun; Eric B Thorndike; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

7.  Effects of L-histidine depletion and L-tyrosine/L-phenylalanine depletion on sensory and motor processes in healthy volunteers.

Authors:  P van Ruitenbeek; A Sambeth; A Vermeeren; S N Young; W J Riedel
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.